NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $8 | $79 | $34 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $24 | $24 | $23 | $26 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $229 | $274 | $297 |
| Total Curr. Assets | $24 | $911 | $1,249 | $1,607 |
| Property Plant & Equip (Net) | $0 | $13,991 | $14,306 | $14,618 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $93 | $93 | $91 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $14,084 | $14,399 | $14,709 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $14,995 | $15,648 | $16,316 |
| Liabilities | – | – | – | – |
| Payables | $0 | $13,451 | $12,694 | $12,835 |
| Short-Term Debt | $0 | $19,700 | $17,275 | $11,565 |
| Tax Payable | $0 | $710 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $1,584 | $19,591 | $11,184 |
| Total Curr. Liab. | $0 | $37,118 | $51,408 | $37,483 |
| LT Debt | $0 | $10,604 | $10,372 | $10,147 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $33 | $33 | $33 |
| Other NC Liab. | $0 | $14,008 | $23,236 | $23,360 |
| Total NC Liab. | $0 | $24,927 | $33,957 | $33,888 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $436 | $470 | $348 |
| Total Liabilities | $0 | $62,045 | $85,365 | $71,371 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $4 | $3 | $2 |
| Retained Earnings | $0 | -$177,002 | -$183,600 | -$167,512 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | -$251 | -$10,706 | -$10,389 |
| Total Equity | $0 | -$47,050 | -$69,717 | -$55,055 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $14,995 | $15,648 | $16,316 |
| Net Debt | $0 | $30,296 | $27,568 | $21,678 |